Key Takeaways
- India drags, RoW delivers: India volumes fell -1% as rising fatty alcohol prices and consumer downtrading persisted, while Rest of World grew double digits on masstige specialty expansion.
- Volume guidance trimmed to lower end: FY26 volume growth now expected at the lower end of the 6%-8% band until India turns around; Q1 FY26 will also be at the lower end.
- EBITDA/MT guidance held at ₹20,500-21,500: Margin expansion levers include raw material pass-through, freight cost reduction, and cost discipline, though freight volatility remains a wildcard.
- Management prioritizes volume over margin: The sales team is instructed not to lose a single metric ton of business, signaling an aggressive stance on market share even if it pressures near-term profitability.
- What to watch next quarter: Whether India volumes stabilize as palm oil prices plateau, whether AMET begins its promised growth, and whether freight rates stay at Q4 levels or spike further.
India: The Core Problem
- Volume contraction persists: India Q4 volume growth was negative 1%, with customers not signaling confidence that growth will resume soon.
- Fatty alcohol price shock: Prices rose more than 40% from Q2 onwards, forcing consumer brands to pass through costs, which triggered demand destruction and downtrading from masstige to low-end products.
- Palm oil cycle mechanics: When palm oil prices stabilize, volume growth typically follows after about 6 months because consumers adjust; the quantum of this price increase has been unusually high, prolonging the adjustment.
- Liquid detergents not yet a savior: Liquid fabric wash momentum is good with more brand launches and urban preference shifts, but at ~100,000 tons versus a 15-20 lakh ton total market, it cannot move overall India volumes meaningfully; per-wash cost remains high.
- Reformulation risk: With crude prices falling and fatty alcohol staying sticky and high, some reformulation from fatty alcohol to petro-based surfactants is occurring; management acknowledges this has happened before but involves formulation challenges and is not a long-term strategy for brands with carbon footprint goals.
Natarajan: "If you see one of major players, global players in home and personal care segment in India has made a very clear statement in terms of how India is critical to their global strategy. And how do they see India contributing significantly to their growth in the years going ahead."
Rest of World: The Offset
- Double-digit growth engine: Rest of World delivered double-digit growth in both Q4 and the full year, driven by continued expansion in Europe, APAC, North and Latin America.
- Masstige specialties driving volumes: The segment posted 17% YTD volume growth, with specialty care products finding traction in developed markets even as India and AMET saw downtrading.
- Americas region leads: Management expects momentum to continue, with the Americas region as the primary driver alongside good performance across Europe and Asia Pacific.
- Unilever Mexico facility: Unilever announced it will build a surfactant facility in Mexico; management declined to provide any numbers citing confidentiality agreements with the customer.
AMET: Waiting for the Turn
- Flat performance in Q4 and full year: Africa, Middle East, Turkey region remained flat amid a challenging macroeconomic environment, though management sees signs of improvement in demand factors and easing supply chain disruptions.
- Growth expected this year: Management expects AMET to start assuming growth momentum in FY26 as supply-side issues have improved; clarity is expected by the end of Q1 FY26.
- Downside scenario quantified: If India stays negative, AMET grows only 2%-3%, and Rest of World grows 9%, Galaxy would deliver only 3.5%-4% volume growth, well below the guided band.
Margins & Cost Structure
- EBITDA/MT guidance intact at ₹20,500-21,500: Expansion drivers include effective pass-through of raw material price increases, reduction in freight costs from easing supply chain constraints, improved yield management, and disciplined cost control.
- Other expenses dropped: Cost optimization efforts, non-recurrence of one-time costs from earlier periods, and lower freight rates contributed to the decline.
- Freight rate volatility is the wildcard: Management acknowledges high volatility can benefit or hurt; contracts locked until June cannot be renegotiated mid-term, but new contracts reflect current freight rates.
- Volume prioritized over margin: The sales team is explicitly focused on not losing a single metric ton of business, with management stating this trade-off clearly.
- Analyst math rejected: An analyst asserted gross margin per kg increased by ₹3/kg in FY25 while EBITDA per kg was flat, and asked if this ₹3 should flow into FY26 EBITDA. Management flatly rejected the framing: "I'm not able to get the way that you're looking at it" and "freight under over recovery impacts you by ₹3 per kilo — no, that's not the case at all."
Natarajan: "So it's like how do you prioritize volume growth over margin growth. That's very clear."
Raw Material Dynamics
- Fatty alcohol prices to stay elevated: Expected to remain at Q3 levels for at least one more quarter due to supply shortages in Southeast Asia and production shutdowns or breakdowns in palm kernel oil manufacturers.
- Petro-oleo substitution underway: When petro-based products are cheaper, brands may temporarily use more petro feedstocks to manage profitability; Galaxy can handle synthetic alcohol-based surfactants and alpha olefin sulfonate, though LABSA will not be done in India.
- Not a long-term strategy: Consumers notice formulation performance differences, and brands prefer oleo-based products for carbon footprint goals; management views the shift as temporary.
- International sea freight restored but fragile: Rates have restored compared to the previous quarter but are affected by postponement of reciprocal tariffs by the US leading to higher container demand, no signs of ships returning to the Suez Canal route, and congestion in Europe, China, and Southeast Asia.
Natarajan: "I would say that this all will be getting to using some Petro feedstocks a little bit higher into the formulation may be a temporary thing that they will have to do from the point of view of managing their profitability, but that's not something we would want to do as part of the long-term strategy."
Innovation Pipeline & Capex
- Specialty ingredients project commissioning: The new specialty ingredients facility is getting commissioned in the first half of this year, with a good portion of the ₹330 crores capex over two years allocated to specialties.
- Pilot plant upgrade: Being commissioned in phases to deliver more reactions and technologies for new products.
- Tri-K new products: Three new products introduced, including "Ever Bond" for treated hair finding strong interest, and another launched at in-cosmetics Amsterdam generating higher growth interest.
- Biosurfactants at pilot stage: Product already at pilot stage; will launch once application studies are complete.
- Galseer DermaGreen gaining traction: Well received from customers with a large pipeline of projects being created; efficacy studies continuing. Management declined to share market size estimates until at least 10 customers have incorporated it into their brands commercially.
- Galguard Prebiotive award: Won the Best Ingredient Silver Award in the functional category at in-cosmetics global exhibition in Amsterdam.
- Capex normalization: No new projects being taken up; normalized capex of ₹150-170 crores may be paused or reduced; replacement capex of ~₹150 crores per year continues for plant revamping and efficiency.
- Calibrated launch cadence: Typically one or two products per year between Galaxy and Tri-K combined; each product takes 3-5 years to fully blossom, so launches are deliberately paced.
Natarajan: "Each product we launch, it takes almost 3 to 5 years for it to blossom fully. So we don't want to spread ourselves too thin. So we do have products that are there in the pipeline to launch, but we launched them in a very calibrated manner."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Volume growth | Lower end of 6%-8% band until India turns around; Q1 FY26 at lower end | FY26, with Q1 update at mid-August call |
| EBITDA/MT | ₹20,500 to ₹21,500 per metric ton | FY26 |
| Fatty alcohol prices | Remain elevated at Q3 levels | At least one more quarter |
| AMET growth | Expected to start assuming growth momentum; clarity by end of Q1 FY26 | FY26, Q1 update |
| Capex | Normalized ₹150-170 crores may be paused or reduced; replacement capex ~₹150 crores continues | FY26 |
| Specialty ingredients project | Commissioning | First half of FY26 |
| India recovery | Expect India to at least start growing at a decent level, not at earlier very high levels | No specific timeline given |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Consolidated EBITDA | ₹135 cr, +23% QoQ |
| EBITDA per metric ton | ₹21,715, +24% QoQ and +5% YoY |
| YTD consolidated EBITDA | ₹510 cr, broadly in line with previous year |
| YTD EBITDA per metric ton | ₹19,868, broadly in line with previous year |
| Volume growth, Rest of World | 9% in Q4, 17% YTD |
| Volume growth, India | negative 1% |
| Volume growth, AMET | flat performance in Q4 and full fiscal year |
| Overall volume growth FY25 | ~3.5% |
| Volume growth guidance FY26 | lower end of 6% to 8% band, subject to India recovery |
| EBITDA per metric ton guidance FY26 | ₹20,500 to ₹21,500 |
| Fatty alcohol price | ~$2,800 per metric ton, up from ~$2,600 in Q3; elevated levels expected for at least one more quarter |
| Fatty alcohol price increase from Q2 | more than 40% |
| Gross margin per kg increase in FY25 | ~₹3 per kg (per an analyst's math), EBITDA per kg flat |
| CWIP in balance sheet | ₹260 cr, majorly skewed towards specialties |
| Capex last 2 years | ~₹300 cr to ₹330 cr |
| Normalized annual capex guidance | ₹150 cr to ₹170 cr |